The association of survival with adjuvant chemotherapy in patients with ypTNM stage I gastric cancer after neoadjuvant chemotherapy | Synapse
February 2, 2026Open Access
The association of survival with adjuvant chemotherapy in patients with ypTNM stage I gastric cancer after neoadjuvant chemotherapy
Key Points
The research aims to determine the impact of adjuvant chemotherapy on survival in patients with ypTNM stage I gastric cancer after neoadjuvant chemotherapy.
Analyzed data from patients with ypTNM stage I gastric cancer.
Compared outcomes between those receiving adjuvant chemotherapy and those who did not.
Utilized nomograms to assess predictive value for patient prognosis.
Postoperative adjuvant chemotherapy was associated with better survival outcomes.
Nomograms effectively predicted prognosis for patients who received adjuvant chemotherapy.
Abstract
Patients with ypTNM stage I GC might benefit from postoperative AC compared with non-AC. Nomograms showed better predictive value for evaluating the prognosis of ypTNM stage I GC patients who received AC.